Profitelligence Profitelligence · Filing Ledger Open A research →

Form 8-K · Current Report · Filed 2026-05-04

Agilent Appoints New Chief Legal Officer

Agilent Technologies, Inc. announced on May 4, 2026, the appointment of Michael Buckner as its new Chief Legal Officer, effective immediately. This follows the resignation of Bret DiMarco, who will remain as a Special Advisor until December 1, 2026. Buckner brings extensive experience from Danaher Corp., where he led legal strategy for mergers and acquisitions, antitrust, intellectual property transactions, and debt securities.

Filer
Agilent Technologies Inc. A · NYSE
Filed
Accession
0001193125-26-202636
CIK
0001090872
Signal
High impactHealthcare

Items reported

Item events

Reported Item

New CEO Appointed CEO Resignation

Market reaction

Close before filing

$114.52

Next session

+2.6%

Since filing

+20.8%

Latest close

$138.37

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from A reporting the same item, with the next session's move:

Insider tape

Within 45 days of this filing, A insiders reported 4 Form 4 transactions — net selling of $317K.

Full A insider history →

About Agilent Technologies Inc.

Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.

Exchange NYSE Industry Diagnostics & Research Company website ↗

Never miss another A filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts